TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Prostate Cancer Therapeutics Drugs Market Research Report 2022

Global Prostate Cancer Therapeutics Drugs Market Research Report 2022

  • Category:Life Sciences
  • Published on : 06 November 2022
  • Pages :98
  • Formats:
  • Report Code:SMR-7479930
OfferClick for best price

Best Price: $2320

Prostate Cancer Therapeutics Drugs Market Size, Share 2022


Market Analysis and Insights: Global Prostate Cancer Therapeutics Drugs Market

The global Prostate Cancer Therapeutics Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Therapeutics Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Therapeutics Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Therapeutics Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Therapeutics Drugs market.

Global Prostate Cancer Therapeutics Drugs Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Sale Channel. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Hormone Therapy

Chemotherapy

Biologic Therapy

Targeted Therapy

Other

Segment by Sale Channel

Hospital Pharmacy

Retail Pharmacy

Online Sales

Other

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Johnson & Johnson

Pfizer, Inc

AstraZeneca

Amgen, Inc

AbbVie, Inc

Bayer AG

Ipsen Group

Sanofi

Endo Pharmaceuticals

Dendreon Corporation

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Prostate Cancer Therapeutics Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Prostate Cancer Therapeutics Drugs, with price, sales, revenue, and global market share of Prostate Cancer Therapeutics Drugs from 2019 to 2022.

Chapter 3, the Prostate Cancer Therapeutics Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Prostate Cancer Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Prostate Cancer Therapeutics Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Prostate Cancer Therapeutics Drugs.

Chapter 13, 14, and 15, to describe Prostate Cancer Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Prostate Cancer Therapeutics Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Prostate Cancer Therapeutics Drugs Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 98 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Prostate Cancer Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Therapeutics Drugs
1.2 Prostate Cancer Therapeutics Drugs Segment by Type
1.2.1 Global Prostate Cancer Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.2.6 Other
1.3 Prostate Cancer Therapeutics Drugs Segment by Sale Channel
1.3.1 Global Prostate Cancer Therapeutics Drugs Sales Comparison by Sale Channel: (2022-2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Other
1.4 Global Prostate Cancer Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Therapeutics Drugs Revenue 2017-2028
1.4.2 Global Prostate Cancer Therapeutics Drugs Sales 2017-2028
1.4.3 Prostate Cancer Therapeutics Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Prostate Cancer Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Prostate Cancer Therapeutics Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Prostate Cancer Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Prostate Cancer Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Prostate Cancer Therapeutics Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prostate Cancer Therapeutics Drugs Players Market Share by Revenue
2.5.3 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostate Cancer Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Prostate Cancer Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Prostate Cancer Therapeutics Drugs Sales by Country
3.3.2 North America Prostate Cancer Therapeutics Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Prostate Cancer Therapeutics Drugs Sales by Country
3.4.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostate Cancer Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Country
3.6.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Prostate Cancer Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)
4.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Prostate Cancer Therapeutics Drugs Price by Type (2017-2022)
5 Global Prostate Cancer Therapeutics Drugs Historic Market Analysis by Sale Channel
5.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)
5.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2017-2022)
5.3 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2017-2022)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Corporation Information
6.2.2 Pfizer, Inc Description and Business Overview
6.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.2.5 Pfizer, Inc Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Amgen, Inc
6.4.1 Amgen, Inc Corporation Information
6.4.2 Amgen, Inc Description and Business Overview
6.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.4.5 Amgen, Inc Recent Developments/Updates
6.5 AbbVie, Inc
6.5.1 AbbVie, Inc Corporation Information
6.5.2 AbbVie, Inc Description and Business Overview
6.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.5.5 AbbVie, Inc Recent Developments/Updates
6.6 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Portfolio
6.6.5 Bayer AG Recent Developments/Updates
6.7 Ipsen Group
6.6.1 Ipsen Group Corporation Information
6.6.2 Ipsen Group Description and Business Overview
6.6.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Portfolio
6.7.5 Ipsen Group Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo Pharmaceuticals
6.9.1 Endo Pharmaceuticals Corporation Information
6.9.2 Endo Pharmaceuticals Description and Business Overview
6.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Portfolio
6.9.5 Endo Pharmaceuticals Recent Developments/Updates
6.10 Dendreon Corporation
6.10.1 Dendreon Corporation Corporation Information
6.10.2 Dendreon Corporation Description and Business Overview
6.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Portfolio
6.10.5 Dendreon Corporation Recent Developments/Updates
7 Prostate Cancer Therapeutics Drugs Manufacturing Cost Analysis
7.1 Prostate Cancer Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostate Cancer Therapeutics Drugs
7.4 Prostate Cancer Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostate Cancer Therapeutics Drugs Distributors List
8.3 Prostate Cancer Therapeutics Drugs Customers
9 Prostate Cancer Therapeutics Drugs Market Dynamics
9.1 Prostate Cancer Therapeutics Drugs Industry Trends
9.2 Prostate Cancer Therapeutics Drugs Market Drivers
9.3 Prostate Cancer Therapeutics Drugs Market Challenges
9.4 Prostate Cancer Therapeutics Drugs Market Restraints
10 Global Market Forecast
10.1 Prostate Cancer Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostate Cancer Therapeutics Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Prostate Cancer Therapeutics Drugs by Type (2023-2028)
10.2 Prostate Cancer Therapeutics Drugs Market Estimates and Projections by Sale Channel
10.2.1 Global Forecasted Sales of Prostate Cancer Therapeutics Drugs by Sale Channel (2023-2028)
10.2.2 Global Forecasted Revenue of Prostate Cancer Therapeutics Drugs by Sale Channel (2023-2028)
10.3 Prostate Cancer Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostate Cancer Therapeutics Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Prostate Cancer Therapeutics Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Prostate Cancer Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Prostate Cancer Therapeutics Drugs Sales Growth Rate Comparison by Sale Channel (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Prostate Cancer Therapeutics Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Prostate Cancer Therapeutics Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Prostate Cancer Therapeutics Drugs Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Prostate Cancer Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Prostate Cancer Therapeutics Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Prostate Cancer Therapeutics Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Prostate Cancer Therapeutics Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Prostate Cancer Therapeutics Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prostate Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Therapeutics Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prostate Cancer Therapeutics Drugs Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Prostate Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Prostate Cancer Therapeutics Drugs Revenue Share by Type (2017-2022)
Table 43. Global Prostate Cancer Therapeutics Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Sale Channel (2017-2022)
Table 45. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)
Table 46. Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 47. Global Prostate Cancer Therapeutics Drugs Revenue Share by Sale Channel (2017-2022)
Table 48. Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2017-2022) & (USD/Pcs)
Table 49. Johnson & Johnson Corporation Information
Table 50. Johnson & Johnson Description and Business Overview
Table 51. Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Johnson & Johnson Prostate Cancer Therapeutics Drugs Product
Table 53. Johnson & Johnson Recent Developments/Updates
Table 54. Pfizer, Inc Corporation Information
Table 55. Pfizer, Inc Description and Business Overview
Table 56. Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. Pfizer, Inc Prostate Cancer Therapeutics Drugs Product
Table 58. Pfizer, Inc Recent Developments/Updates
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Description and Business Overview
Table 61. AstraZeneca Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. AstraZeneca Prostate Cancer Therapeutics Drugs Product
Table 63. AstraZeneca Recent Developments/Updates
Table 64. Amgen, Inc Corporation Information
Table 65. Amgen, Inc Description and Business Overview
Table 66. Amgen, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Amgen, Inc Prostate Cancer Therapeutics Drugs Product
Table 68. Amgen, Inc Recent Developments/Updates
Table 69. AbbVie, Inc Corporation Information
Table 70. AbbVie, Inc Description and Business Overview
Table 71. AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. AbbVie, Inc Prostate Cancer Therapeutics Drugs Product
Table 73. AbbVie, Inc Recent Developments/Updates
Table 74. Bayer AG Corporation Information
Table 75. Bayer AG Description and Business Overview
Table 76. Bayer AG Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Bayer AG Prostate Cancer Therapeutics Drugs Product
Table 78. Bayer AG Recent Developments/Updates
Table 79. Ipsen Group Corporation Information
Table 80. Ipsen Group Description and Business Overview
Table 81. Ipsen Group Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. Ipsen Group Prostate Cancer Therapeutics Drugs Product
Table 83. Ipsen Group Recent Developments/Updates
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Business Overview
Table 86. Sanofi Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Sanofi Prostate Cancer Therapeutics Drugs Product
Table 88. Sanofi Recent Developments/Updates
Table 89. Endo Pharmaceuticals Corporation Information
Table 90. Endo Pharmaceuticals Description and Business Overview
Table 91. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product
Table 93. Endo Pharmaceuticals Recent Developments/Updates
Table 94. Dendreon Corporation Corporation Information
Table 95. Dendreon Corporation Description and Business Overview
Table 96. Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. Dendreon Corporation Prostate Cancer Therapeutics Drugs Product
Table 98. Dendreon Corporation Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Prostate Cancer Therapeutics Drugs Distributors List
Table 102. Prostate Cancer Therapeutics Drugs Customers List
Table 103. Prostate Cancer Therapeutics Drugs Market Trends
Table 104. Prostate Cancer Therapeutics Drugs Market Drivers
Table 105. Prostate Cancer Therapeutics Drugs Market Challenges
Table 106. Prostate Cancer Therapeutics Drugs Market Restraints
Table 107. Global Prostate Cancer Therapeutics Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 108. Global Prostate Cancer Therapeutics Drugs Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Prostate Cancer Therapeutics Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Prostate Cancer Therapeutics Drugs Sales Forecast by Sale Channel (2023-2028) & (K Pcs)
Table 112. Global Prostate Cancer Therapeutics Drugs Sales Market Share Forecast by Sale Channel (2023-2028)
Table 113. Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Sale Channel (2023-2028) & (US$ Million)
Table 114. Global Prostate Cancer Therapeutics Drugs Revenue Market Share Forecast by Sale Channel (2023-2028)
Table 115. Global Prostate Cancer Therapeutics Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 116. Global Prostate Cancer Therapeutics Drugs Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Prostate Cancer Therapeutics Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prostate Cancer Therapeutics Drugs
Figure 2. Global Prostate Cancer Therapeutics Drugs Market Share by Type in 2021 & 2028
Figure 3. Hormone Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Biologic Therapy Product Picture
Figure 6. Targeted Therapy Product Picture
Figure 7. Other Product Picture
Figure 8. Global Prostate Cancer Therapeutics Drugs Market Share by Sale Channel in 2021 & 2028
Figure 9. Hospital Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Online Sales
Figure 12. Other
Figure 13. Global Prostate Cancer Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Prostate Cancer Therapeutics Drugs Market Size (2017-2028) & (US$ Million)
Figure 15. Global Prostate Cancer Therapeutics Drugs Sales (2017-2028) & (K Pcs)
Figure 16. Prostate Cancer Therapeutics Drugs Sales Share by Manufacturers in 2021
Figure 17. Global Prostate Cancer Therapeutics Drugs Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Prostate Cancer Therapeutics Drugs Players: Market Share by Revenue in 2021
Figure 19. Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2017-2022)
Figure 21. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Region in 2021
Figure 22. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Figure 23. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Region in 2021
Figure 24. U.S. Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. China Taiwan Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Prostate Cancer Therapeutics Drugs by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Prostate Cancer Therapeutics Drugs
Figure 48. Manufacturing Process Analysis of Prostate Cancer Therapeutics Drugs
Figure 49. Prostate Cancer Therapeutics Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount